Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Queensland Health
Federal Trade Commission
Covington
Accenture
Chubb
Medtronic
QuintilesIMS

Generated: December 13, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for CLARAVIS

« Back to Dashboard

Payment Methods and Pharmacy Types for CLARAVIS (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE ANOTHER STORE $56,005,029
INSIDE HMO/CLINIC/HOSPITAL $49,524,771
[disabled in preview] $267,021,984
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE ANOTHER STORE 178,638
INSIDE HMO/CLINIC/HOSPITAL 93,144
[disabled in preview] 638,748
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $44,841,083
PRIVATE INSURANCE $271,648,451
[disabled in preview] $56,062,249
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for CLARAVIS
Drug Units Sold Trends for CLARAVIS

Annual Sales Revenues and Units Sold for CLARAVIS

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
CLARAVIS ➤ Try a Free Trial ➤ Try a Free Trial 2016
CLARAVIS ➤ Try a Free Trial ➤ Try a Free Trial 2015
CLARAVIS ➤ Try a Free Trial ➤ Try a Free Trial 2014
CLARAVIS ➤ Try a Free Trial ➤ Try a Free Trial 2013
CLARAVIS ➤ Try a Free Trial ➤ Try a Free Trial 2012
CLARAVIS ➤ Try a Free Trial ➤ Try a Free Trial 2011
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Cipla
Moodys
Colorcon
Express Scripts
Citi
Teva
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.